Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bioproperties pty. ltd. - mycoplasma gallisepticum strain ts-11 - misc. vaccines or anti sera - mycoplasma gallisepticum strain ts-11 vaccine-general active 0.0 ccu/dose - immunotherapy - poultry layers (eggs for human consump) | caged layers | chickens | chooks | hen - chronic respiratory disease | mycoplasma gallisepticum | vaccine | chronic respiratory disease (c | equine rotavirus | infectious sinusitis

European Union - English - EMA (European Medicines Agency)

dendreon uk ltd - autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous cd54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor - prostatic neoplasms - other immunostimulants - provenge is indicated for treatment of asymptomatic or minimally symptomatic metastatic (non-visceral) castrate-resistant prostate cancer in male adults in whom chemotherapy is not yet clinically indicated.

United States - English - NLM (National Library of Medicine)

app pharmaceuticals, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - these parenteral preparations are indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.  not for inhalation. bacteriostatic sodium chloride injection, usp, 0.9% should not be used for fluid or sodium chloride replacement.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698) - sodium chloride 9 mg in 1 ml - these parenteral preparations are indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.   not for inhalation . due to potential toxicity of benzyl alcohol in newborns, bacteriostatic sodium chloride injection, usp, 0.9% containing benzyl alcohol must not be used in this patient population. bacteriostatic sodium chloride injection, usp, 0.9% should not be used for fluid or sodium chloride replacement.

United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - this parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered. due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. parenteral preparations with benzyl alcohol should not be used for fluid replacement. parenteral preparations containing benzyl alcohol should not be used in epidural or spinal anesthesia procedures. bacteriostatic water for injection, usp must be made approximately isotonic prior to use.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - these parenteral preparations are indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered. sterile water for injection, usp and bacteriostatic water for injection, usp must be made approximately isotonic prior to use. bacteriostatic water for injection should not be used in patients with a known sensitivity to the antimicrobial preservative employed.

Australia - English - Department of Health (Therapeutic Goods Administration)

johnson & johnson medical pty ltd - 52751 - haemostatic-agent endotherapy cannula - intended for use in delivering hemostatic agents to bleeding sites through a trocar.

Australia - English - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 58882 - prostatic retraction implant - the urolift system is intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (bph) in men over the age of 50.